Friedenthal Financial’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-1,189
| Closed | -$117K | – | 334 |
|
2024
Q3 | $117K | Buy |
+1,189
| New | +$117K | 0.07% | 124 |
|
2024
Q2 | – | Sell |
-1,305
| Closed | -$124K | – | 295 |
|
2024
Q1 | $124K | Buy |
1,305
+17
| +1% | +$1.61K | 0.08% | 120 |
|
2023
Q4 | $115K | Buy |
+1,288
| New | +$115K | 0.08% | 117 |
|
2022
Q4 | – | Sell |
-60,856
| Closed | -$4.83M | – | 116 |
|
2022
Q3 | $4.83M | Buy |
+60,856
| New | +$4.83M | 3.36% | 14 |
|
2021
Q2 | – | Sell |
-41,652
| Closed | -$5.65M | – | 74 |
|
2021
Q1 | $5.65M | Buy |
+41,652
| New | +$5.65M | 4.16% | 9 |
|
2020
Q1 | – | Sell |
-46,110
| Closed | -$4.39M | – | 55 |
|
2019
Q4 | $4.39M | Buy |
+46,110
| New | +$4.39M | 3.34% | 8 |
|